Faculty Information - Tomohiro Fujii

（Last updated : 2025-02-27 10:13:52）

Tomohiro Fujii
Department Kawasaki Medical School Kawasaki Medical School, Department of Urology,

Position Associate Professor

■ Journal Articles

1.	2022/01/19	Anti-inflammatory effect of tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, in autoimmune prostatitis
2.	2020	Outcomes of robot-assisted partial nephrectomy in the treatment of renal cell carcinoma at Kawasaki Medical School Hostiptal
3.	2019/03	Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy.
4.	2018	Male squirting: Analysis of one case using color Doppler ultrasonography
5.	2016/11	Tadalafil for male lower urinary tract symptoms improves endothelial function
6.	2015/06	Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction
7.	2012/03	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
8.	2012/01	Comparison of two different alpha1-adrenoceptor antagonists, tamsulosin hydrochloride and silodosin, in the treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective randomized crossover study.
9.	2011/06	Retroperitoneoscopic Nephrectomy for Treatment of a Case of Left Single Ectopic Ureter Accompanied by Dysplastic Kidney
10.	2011/03	Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia
11.	2009/10	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy?
12.	2009/10	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
13.	2009/04	Is primary hormone therapy efficient for clinically localized prostate cancer in Japanese men?
14.	2009/04	Naftopidil and Propiverin Hydrochrolide for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study
15.	2009/04	The effect of purified newly developed Botulinum neurotoxin type A in rat and human prostate
16.	2008/10	Ejaculatory dysfunction caused by new A1-blocker:analysis of human ejaculatory phenomenon using color doppler ultrasonigraphy
17.	2008/06	A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy.
18.	2008/02	Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
19.	2007/12	The experience of using dual lumen ureteral access sheath (AquaGuide TM)in ureteropyeloscopy
20.	2006/10	Hydronephrosis caused by intra-abdominal abscess from cecal perforation by an ingested fish bone
21.	2006/01	Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores
22.	2005/07	Radical prostatectomy vs high-dose-rate brachytherapy for prostate cancer: Health related quality-of-life effects
23.	2004/09	High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.(共著)
24.	2004/07	Erectile function after brachytherapy with external beam radiation for prostate cancer
25.	2004/05	Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.
26.	2004/05	Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells
27.	2003/09	IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
28.	2003/08	Expression of HER family receptors and effects of anti-HER2-antibody on human myeloma cell lines.
29.	2003/02	Expression of angiogenic factors including VEGFs and the effects of hypoxia and thalidomide on human myeloma cells.
30.	2002/05	Effect of hypoxia on human seminoma cells.
31.	2001/09	Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
32.	2001/07	Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract.
33.	2000/04	Preclinical Cushing's syndrome: report of seven cases and a review of the literature.
Display 5 items
Display all(33)

■ Presentations

1.	2024/04/27	Catheterization with Laparoscopic CAPD using the Peritoneal Wall Anchor Technique at Kawasaki Medical School Hospital （Poster notice，General）
2.	2023/10	A Study on the continuity of drug treatment for benign prostatic hyperplasia （Poster notice，General）
3.	2023/04/20	川崎医科大学附属病院における転移性腎癌に対する免疫複合療法の治療成績 Outcomes of Combined Immunotherapy for Metastatic Renal Cancer at Kawasaki Medical School Hospital （Poster notice，General）
4.	2023/04/20	未治療限局性前立腺癌を対象としたMRI-US 画像融合下限局高線量率組織内照射療法(MRI-US fusion-guided ultrafocal high-dose-rate brachytherapy) の初期経験(第2 報) A prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose-rate brachytherapy (HDR-BT) for primary localized prostate cancer （Poster notice，General）
5.	2020/07	90 Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate （Poster notice，General）
6.	2020/07	New pathological subtype of renal cell carcinoma in patients on long-term dialysis: acquired cystic disease-associated renal cell carcinoma （General）
7.	2020/07	Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction （Poster notice，General）
8.	2019/11/09	Preventive effect of tadalafil for chronic inflammation in the prostate （Speech，General）
9.	2019/10/19	Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease （Poster notice，General）
10.	2019/10/19	Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. （Poster notice，General）
11.	2019/04/11	The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update （Poster notice，General）
12.	2019/03/17	Changes in circulating blood volume measured by pulse dye-densitometry during preoperative management with an α-blocker in patients with pheochromocytoma （Poster notice，General）
13.	2019/03/17	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
14.	2018/09/23	Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A （Speech，General）
15.	2018/05/18	Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer （Speech，General）
16.	2018/04/19	The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis （Speech，General）
17.	2017/10/19	Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients （Poster notice，General）
18.	2017/05/12	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
19.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Poster notice，General）
20.	2017/03/24	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Poster notice，General）
21.	2017/03/24	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
22.	2017/01/14	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Poster notice，General）
23.	2016/11/11	Endoscopic removal of Memotherm^R using holmium YAG laser:A report of 3 cases （Poster notice，General）
24.	2016/11/11	Initial experience with the EMARO pneumatic laparoscopic holder robot in laparoscopic urological surgery
25.	2016/11/11	Therapeutic results and complications of ureteroscopic lithotripsy （Poster notice，General）
26.	2016/05/07	Tadalafil for male LUTS improves endothelial function （Speech，General）
27.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
28.	2016/04/02	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Speech，General）
29.	2016/04/01	Pilot study of penile brachial index for Erectile Dysfunction （Speech，General）
30.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
31.	2015/02	Evaluation of vascular endothelial function for patients with Erectile Dysfunction （Poster notice，General）
32.	2015/02	Maintenance of oral administration of anticholinergic drugs for overactive bladder （Poster notice，General）
33.	2014/10/23	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP). （Speech）
34.	2014/09/04	Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases （Speech，General）
35.	2013/11/07	The relationships between salivary testosterone, serum sex hormones and lower urinary tract symptoms, sexual function in patients with benign prostate hyperplasia. （Speech，General）
36.	2013/11/07	Use of PDE5 inhibitors in elderly at Kawasaki medical school. （Speech，General）
37.	2013/10/24	A peritoneal wall anchor technique using a new device for laparoscopy-assisted catheter placement in peritoneal dialysis （Speech，General）
38.	2013/09/11	Spectrum of renal cell carcinoma histological subtypes arising end-stage renal disease. （Poster notice，General）
39.	2013/09/09	Change of Urinary, Sexual, and Bowel Function after Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia. （Poster notice，General）
40.	2013/09/09	The Relationships between Salivary Testosterone, Serum Sex Hormones and Lower Urinary Tract Symptoms, Sexual Function in Patients with Benign Prostate Hyperplasia. （Poster notice，General）
41.	2013/03/16	Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell carcinoma patients （Poster notice，General）
42.	2013/02/14	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP) （Poster notice，General）
43.	2013/02/14	Comparison of transperineal and transrectal 12-core initial prostate biopsy with PSA levels between 4.0 and 20.0 ng/ml （Speech，General）
44.	2012/10/01	Long-Term Compliance and Treatment Failure of alpha1-Blocker for Patients with Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. （Poster notice，General）
45.	2012/09/07	Incidental Prostate Cancer in Holmium Laser Enucleation of the Prostate (HoLEP) （Poster notice，General）
46.	2012/09/05	Prognostic factors in subsequent development of bladder cancer after the surgical management of primary upper urinary tract urothelial carcinoma （Poster notice，General）
47.	2012/08/04	Analysis of human ejaculation using color Doppler ultrasonography （Speech，Panelist at Symposium/Workshop (Other)）
48.	2012/08/04	Evaluation of patients with symptoms of male andropause （Poster notice，General）
49.	2012/05/22	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
50.	2012/05/21	Clinical efficacy of a new botulinum toxin type A free of complexing proteins in the treatment of refractory neurogenic and idiopathic detrusor overactivity （Poster notice，General）
51.	2012/05/21	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Speech，General）
52.	2012/04/23	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
53.	2012/02/04	Use of Fuhrman grading system for Japanese patients with renal cell carcinoma （Poster notice，General）
54.	2011/10/29	Forty percent of patients with ureteral stones who visit the emergency room first are not followed by urologists. （Speech，General）
55.	2011/10/29	Health-Related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis. （Speech）
56.	2011/10/29	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after initial treatment. （Speech，General）
57.	2011/10/19	Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study （Poster notice，General）
58.	2011/10/19	Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder （Poster notice，General）
59.	2011/10/18	Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy （Poster notice，General）
60.	2011/10/18	Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia （Poster notice，General）
61.	2011/10/17	Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml （Speech，General）
62.	2011/10/17	Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients （Poster notice，General）
63.	2011/10/17	Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor （Poster notice，General）
64.	2011/08/31	Correlation of urinary nerve growth factor level with the response of antimuscarinic therapy in patients with overactive bladder （Poster notice，General）
65.	2011/08/31	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
66.	2009/11/03	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy? （Poster notice，General）
67.	2009/11/01	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
68.	2008/09/20	Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy. （Speech，General）
69.	2008/09/20	Optimal approach for prostate cancer detection as initial biopsy:A prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. （Speech，General）
70.	2007/11/17	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech）
71.	2007/09/02	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech，General）
72.	2007/05/19	Correlation　of urinary nerve growth factor level with pathogenesis of overactive bladder （Poster notice）
73.	2007/05/19	Ejaculatory dysfunction caused by new A1-blocker: analysis of human ejaculatory phenomenon using color doppler ultrasonography （Speech）
74.	2006/09/15	The experience of using dual lumen ureteral access sheath (AquaGuideTM) in ureteropyeloscopy （General）
75.	2004/10/03	What is the neurovascular bundle in urologic surgery? -tha discrepancy between the classical concept and recent findings-. （General）
Display 5 items
Display all(75)